Kenvue Inc. Chief Scientific Officer Caroline Tillett filed a Form 4 on November 4, 2026, disclosing the disposition and conversion of all her directly held Kenvue common stock, stock options, restricted stock units, and performance stock units following Kimberly-Clark Corporation's acquisition of Kenvue on November 2, 2026.
Key Highlights
- Merger completed November 2, 2026: Kimberly-Clark Corporation acquired Kenvue Inc. pursuant to an Agreement and Plan of Merger dated November 2, 2025.
- Common stock disposed: Tillett's 77,709 shares of Kenvue common stock were disposed of, with 0 shares remaining directly owned following the transaction.
- Merger consideration: Each share of Kenvue common stock was exchanged for 0.14625 shares of K-C common stock plus $3.50 in cash, according to the filing.
- Seven stock option tranches converted: Options with exercise prices ranging from $19.01 to $23.92 per share, covering a combined 569,819 underlying shares, were assumed and converted into K-C options, with 0 Kenvue options remaining.
- RSUs converted: 79,075 Kenvue restricted stock units were assumed and converted into equivalent K-C awards, leaving 0 Kenvue RSUs outstanding.
- PSU achievement levels set: PSUs granted December 7, 2023 converted at 128.3% of target; PSUs granted in 2024 and 2025 converted at 100% of target, as determined by the Compensation and Human Capital Committee.
- Post-transaction Kenvue holdings: Following all reported transactions, Tillett's directly held beneficial ownership of Kenvue securities in every category listed stands at 0.
Tillett's Kenvue Equity Converted to K-C Awards Upon Merger Closing
According to the filing, Kimberly-Clark Corporation completed its acquisition of Kenvue Inc. on November 2, 2026, under a merger agreement originally dated November 2, 2025, involving merger subsidiaries Vesta Sub I, Inc. and Vesta Sub II, LLC, both wholly owned by K-C. Under the transaction terms described in the filing, each outstanding share of Kenvue common stock was exchanged for 0.14625 shares of K-C common stock (par value $1.25 per share) plus $3.50 in cash. Tillett's 77,709 shares of Kenvue common stock were disposed of on November 2, 2026, with no shares remaining in direct ownership.
The filing reports that all seven tranches of Tillett's Kenvue stock options, with exercise prices of $19.01, $20.32, $20.81, $21.97, $22.23, $22.40, and $23.92, were assumed and converted into options to acquire K-C common stock. The number of shares and exercise prices were adjusted according to an equity award exchange ratio determined under a formula in the Merger Agreement, the filing states. All converted options covered a combined 569,819 shares of Kenvue common stock prior to conversion, and 0 Kenvue options remain outstanding for Tillett.
Tillett's 79,075 Kenvue RSUs were converted into K-C stock awards based on the equity award exchange ratio, subject to the same terms and conditions that applied prior to closing, the filing notes. For performance stock units, the filing discloses that PSUs granted on December 7, 2023 were converted at 128.3% of target achievement, as determined by the Compensation and Human Capital Committee of Kenvue's Board of Directors, while PSUs granted in 2024 and 2025 converted at 100% of target. The filing records both acquisition and disposal entries for the PSU tranches, with resulting Kenvue PSU ownership at 0.
What Was Disclosed
Kenvue Chief Scientific Officer Caroline Tillett reported the full disposition and conversion of all her Kenvue common stock, stock options, RSUs, and PSUs on November 2, 2026, upon the closing of Kimberly-Clark Corporation's acquisition of Kenvue Inc., (NYSE:KVUE) leaving zero beneficial ownership of any Kenvue securities.



Please wait processing your request...